NYSE · Healthcare
SELECT MEDICAL HOLDINGS CORP (SEM)
As-reported financials and recent SEC filings for SELECT MEDICAL HOLDINGS CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.45B
Net income
$146.2M
Net margin
2.7%
Diluted EPS
$1.16
ROE
7.2%
P/E (TTM)
15.4×
Market cap
$2.05B
Debt / equity
0.9×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.45B | $5.19B | $4.83B | $4.61B | $6.20B |
| Gross profit | — | — | — | — | — |
| Operating income | $336.2M | $268.3M | $267.2M | $144.8M | $713.8M |
| Net income | $146.2M | $214.0M | $243.5M | $159.0M | $402.2M |
| Diluted EPS | $1.16 | $1.66 | $1.91 | $1.23 | $2.98 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-26
View on EDGAR →8-K2026-06-22
View on EDGAR →SC 13E3/A2026-05-20
View on EDGAR →DEFM14A2026-05-20
View on EDGAR →SC 13E3/A2026-05-15
View on EDGAR →PRER14A2026-05-15
View on EDGAR →SCHEDULE 13G2026-05-14
View on EDGAR →42026-05-05
View on EDGAR →Go deeper on SEM
Search SELECT MEDICAL HOLDINGS CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.